HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Allergan Continues Legal Sparring With Cosmetic Eyelash-Growth Brands

This article was originally published in The Rose Sheet

Executive Summary

Latisse marketer Allergan continues to lock horns with cosmetic firms offering non-FDA-approved, prostaglandin-based eyelash-enhancement products, pursuing injunction and damages in California court.

Related Content

Tennessee AG Settles With Cosmetic Lash-Enhancer Brands; Sales Cease
In Brief
Coty/Rimmel Targeted With Suit Over Lash Accelerator Claims
FDA’s Warning To Lash-Growth Firm Shows Risks In Third-Party Claims
FDA approves Allergan eyelash enhancer
Jan Marini Focused On Damage Control Following FDA Seizure Of Eyelash Item



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts